LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.32 Cr | ₹2.84 Cr | ₹6.54 Cr | ₹8.41 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹5.32 Cr |
| Mar2023 | ₹2.84 Cr |
| Mar2022 | ₹6.54 Cr |
| Mar2021 | ₹8.41 Cr |
| Mar2020 | ₹11 Cr |
How is Total Non-Current Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.32 Cr | 87.33 | |
| Mar2023 | ₹2.84 Cr | -56.54 | |
| Mar2022 | ₹6.54 Cr | -22.25 | |
| Mar2021 | ₹8.41 Cr | -26.44 | |
| Mar2020 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹44.5 Cr | -1.3% | -22.8% | -64.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,991.0 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -1.3% |
-22.8% |
-64.8% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses